Home/ Supplements/ Omega 3/ Omega 3-6-9 1000 mg

Omega 3-6-9 1000 mg

product on market Softgel Capsule NOW Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 14% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This blend contains flax seed, evening primrose, and canola oils to provide a variety of omega fatty acids. Research suggests these ingredients may support cardiovascular and inflammatory health, though evidence for this specific combined formulation is limited. The profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega 3-6-9 1000 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
125
Servings
Fat/Fatty Acid
Product Type
14%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
1.4 Gram(s)
Market median: 1000.0mg (212 products) 12 studies (A:0, B:3)
Evening Primrose Oil
300 mg
Canola Oil
260 mg
Black Currant Oil
20 mg
Pumpkin seed Oil
20 mg

Other Ingredients

Softgel Capsule
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: Take 2 softgels daily with a meal.

Warnings & Precautions

Caution: For adults only.

Consult physician if taking medication or have a medical condition.

Keep out of reach of children.

Not manufactured with yeast, wheat, gluten, soy, milk, egg, fish or shellfish ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.

Formulation Notes

Omega 3-6-9 is a blend of Flax Seed, Evening Primrose, Canola, Black Currant and Pumpkin Seed Oils. NOW combines these well-known nutritional oils to create balanced proportions of Omega-3, Omega-6 and Omega-9 fatty acids.

Each serving may also have the following naturally occurring amounts of polyunsaturated fats and monounsaturated fats: Omega-3 [Alpha Linolenic Acid (ALA)] 45%; Omega-6 [Linoleic Acid and Gamma Linolenic Acid (GLA)] 26.5%; Omega-9 [Oleic Acid] 17.5%; Other (short chain fatty acids, saturated fats, phospholipids, etc) 11%

Hexane-free

Triangle K Contains gelatin

Contains Gelatin

Not manufactured with yeast, wheat, gluten, soy, milk, egg, fish or shellfish ingredients.

Non-GMO

Additional Information

The Omega-3, Alpha Linolenic Acid (ALA), and the Omega-6, GLA, play important roles in the maintenance of healthy skin and immune system function.* Dietary Oleic Acid, a monounsaturated Omega-9 fatty acid, has been associated with healthy cardiovascular function.*

Natural color variation may occur in this product.

Store in a cool, dry place after opening.

Please recycle.

Softgel size

CODE 1837 V6

Essential fatty acids

~ Blend of five nutritional oils ~ Healthy skin and immune support*

Triagnle K Contains gelatin

Nutritional oils

Family owned since 1968.

GMP Quality Assured

Non-GMO

Metadata

Product Details

UPC / SKU7 33739 01837 3
DSLD Entry Date2017-03-24
Product TypeFat/Fatty Acid
FormSoftgel Capsule
BrandNOW
DSLD ID70837
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.